EUVIMEDEUVIMED entdecken
Open Access

CH02 peptide promotes <italic>ex vivo</italic> expansion of umbilical cord blood-derived CD34<sup>+</sup> hematopoietic stem/progenitor cells

Yiqi Yang, Bihui Zhang, Junye Xie, Jingsheng Li, Jia Liu, Rongzhan Liu, Linhao Zhang, Jinting Zhang, Zijian Su, Fu Li, Leisheng Zhang, An Hong und 1 weitere

Acta Biochimica et Biophysica Sinica · 2023

DOI: 10.3724/abbs.2023047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2023. Verfasst von Yiqi Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Guangdong Province Key Laboratory of Bioengineering Me…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Umbilical cord blood (UCB) is an advantageous source for hematopoietic stem/progenitor cell (HSPC) transplantation, yet the current strategies for large-scale and cost-effective UCB-HSPC preparation are still unavailable. To overcome these obstacles, we systematically evaluate the feasibility of our newly identified CH02 peptide for ex vivo expansion of CD34 + UCB-HSPCs. We herein report that the CH02 peptide is specifically enriched in HSPC proliferation via activating the FLT3 signaling. Notably, the CH02-based cocktails are adequate for boosting 12-fold ex vivo expansion of UCB-HSPCs. Meanwhile, CH02-preconditioned UCB-HSPCs manifest preferable efficacy upon wound healing in diabetic mice via bidirectional orchestration of proinflammatory and anti-inflammatory factors. Together, our data indicate the advantages of the CH02-based strategy for ex vivo expansion of CD34 + UCB-HSPCs, which will provide new strategies for further development of large-scale HSPC preparation for clinical purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalHematopoietic Stem Cell TransplantationAnimalsMiceFetal BloodHematopoietic Stem CellsAntigens, CD34Cell Adhesion MoleculesPeptidesCells, Cultured

Stichwörter der Autor:innen

CD34 hematopoietic stem/progenitor cellCH02 peptideFms-like tyrosine kinase receptor 3umbilical cord bloodwound healing

Substanzen

Antigens, CD34Cell Adhesion MoleculesPeptides

Autor:innen und Institutionen

  • Institute of Biomedicine & Department of Cell Biology, College of Life Science and Technology, Guangdong Province Key Laboratory of Bioengineering Medicine, Guangdong Provincial Biotechnology Drug & Engineering Technolo…
  • The First Affiliated Hospital, Ji'nan University, Guangzhou 510630, China.
  • Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province & NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou 730000,…
  • Key Laboratory of Radiation Technology and Biophysics, Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.

Zitieren

APA

Yang, Y., Zhang, B., Xie, J., Li, J., Liu, J., Liu, R., Zhang, L., Zhang, J., Su, Z., Li, F., Zhang, L., Hong, A., & Chen, X. (2023). CH02 peptide promotes ex vivo expansion of umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023047

Vancouver

Yang Y, Zhang B, Xie J, Li J, Liu J, Liu R, et al. CH02 peptide promotes ex vivo expansion of umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells. Acta Biochimica et Biophysica Sinica. 2023. doi:10.3724/abbs.2023047

BibTeX
@article{Yang2023,
  author = {Yang, Yiqi and Zhang, Bihui and Xie, Junye and Li, Jingsheng and Liu, Jia and Liu, Rongzhan and Zhang, Linhao and Zhang, Jinting and Su, Zijian and Li, Fu and Zhang, Leisheng and Hong, An and Chen, Xiaojia},
  title = {CH02 peptide promotes ex vivo expansion of umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2023},
  doi = {10.3724/abbs.2023047}
}
Kostenlos starten →